Clinical Trials Directory

Trials / Completed

CompletedNCT02244346

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Status
Completed
Phase
—
Study type
Observational
Enrollment
811 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
Male
Age
—
Healthy volunteers
Not accepted

Summary

Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice

Conditions

Interventions

TypeNameDescription
DRUGSecotex®

Timeline

Start date
2004-05-01
Primary completion
2004-11-01
First posted
2014-09-19
Last updated
2014-09-19

Source: ClinicalTrials.gov record NCT02244346. Inclusion in this directory is not an endorsement.

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) (NCT02244346) · Clinical Trials Directory